Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Nuvalent Inc NUVL

Healthcare Biotechnology
Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases and drive more durable responses. It is advancing a robust pipeline with investigational candidates for ROS1... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:NUVL)

Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024

PR Newswire April 8, 2024

Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, zidesamtinib, at AACR Annual Meeting 2024

PR Newswire March 5, 2024

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results

PR Newswire February 27, 2024

Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520

PR Newswire February 27, 2024

Nuvalent Initiates the Phase 2 Portion of ALKOVE-1 Clinical Trial for Patients with ALK-Positive NSCLC and other Solid Tumors

PR Newswire February 12, 2024

Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

PR Newswire February 1, 2024

Nuvalent Announces "OnTarget 2026" Operating Plan and Key Anticipated Milestones

PR Newswire January 8, 2024

Nuvalent to Present at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire December 21, 2023

Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter 2023 Financial Results

PR Newswire November 14, 2023
View More News ››

Opinion & Analysis (NDAQ:NUVL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NUVL)

eiger and nixxo

New to this board. any ideas when these two will start to work together in producing effective business in saling real products to real...
mercure - March 3, 2001

Harmony and Nixxo

eiger technology (AXA) is playing a major part in all of this. Best thing I can suggest is for those interested to go to SEDAR and print...
metmr - February 22, 2001

RE: new info on this board from CANADA EH?

Ive heard that nixxo may not be using harmony as their shell to go public. Has anyone heard similar rumours.
redln - February 10, 2001

new info on this board from CANADA EH?

Nixxo 25% owned by Eiger axa on the Toronto exchange. You will get more onfo re merger and the type of things you can see Harmony doing....
metmr - February 8, 2001

Could hit $5 soon!!!!

My close source says this could hit $5 soon, and to keep my eye on it. I can't believe, I have known about this stock since it was...
diggler69 - December 11, 2000

RE: HAS SOME ONE TELL ME..

Todya the stock split has been done 1-3.
Vanbram - December 5, 2000
View more Bullboard ››

SEGO Resources Inc

SEGO Resources Inc

SEGO Resources Inc. is a Canada-based exploration stage company. The Company is engaged in the acquisition, exploration, and ...
View More »